−69.83MXN
−11.90 BMXN
38.28 BMXN
170.19 M
About SEAGEN INC
Seattle Genetics is a clinical-stage biotechnology company that focuses on developing and commercializing monoclonal antibody-based therapies for the treatment of cancer and autoimmune diseases. Its lead product, SGN-35, is in the pivotal trial for patients with relapsed or refractory Hodgkin lymphoma. The company's other product candidates in various stages of clinical trials include dacetuzumab (SGN-40), a humanized anti-CD40 antibody; lintuzumab (SGN-33), a humanized anti-CD33 antibody; SGN-70, a humanized anti-CD70 antibody for the treatment of autoimmune diseases; SGN-75, which is in Phase I clinical trials for metastatic renal cell carcinoma and non-Hodgkin lymphoma; ASG-5ME, a preclinical antibody-drug conjugate product candidate for the treatment of solid tumors; and SGN-19A, a preclinical antibody-drug conjugate product candidate for the treatment of hematologic malignancies. It has collaborations with Bayer Pharmaceuticals Corporation; Celldex Therapeutics, Inc.; Daiichi Sankyo Co., Ltd.; Genentech; GlaxoSmithKline LLC; MedImmune, Inc.; Millennium; PSMA Development Company LLC; and Genmab A/S. The company also has an antibody-drug conjugates co-development agreement with Agensys, Inc. The company was founded in 1997 and is headquartered in Bothell, Washington.
$SGEN gapping to new highsStock gapped up on earnings and then today gapped up to new 52 Week highs, which is a very encouraging sign.
Would enter right here @ 177 with a stop @ 159 and a target of 212
6/6/2022 NASDAQ (SGEN)Buy (Entry Price) above the black line and exit (Stop Loss) below the red line. Can take profit at the suggested Target Price.
Entry Price: $140.33
Target Price: $143.70
Stop Loss: $134.69
$SGEN Trying to break out of its weekly trading range$SGEN
Trying to break out of its weekly trading range.
Cheers to those who got this 135-150 consolidation range.
$SEGN Breakout$SEGN Breakout in 1h Chart on above average volume after consolidation phase
All Entry Criteria have been met:
1. Price above 10, 20 & 50 EMA --> Check
2. Consolidation Phase in Uptrend --> Check
3. Breakout on above average Volume --> Check
$SGEN with a Bearish outlook following its earnings #Stocks The PEAD projected a Bearish outlook for $SGEN after a Positive over reaction following its earnings release placing the stock in drift B with an expected accuracy of 100%.
SGEN bottom channelUsusally prefer to wait for ADX but the bottom channel has proven to be a play for quite some time. Tight Stop loss on this one.
$SGEN Cup and Handle?$SGEN may be forming the “cup” of a cup and handle formation. I would look to see if it corrects its advance soon to develop the handle.
SGENGot in a little prematurely and added to the position with a cross on the adx and bounce of the confirmed trendline
SGEN long on C&H confirmationLooking to take SGEN long with a break of 165, eyeing 12/17 185c for 5.50.
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of SGEN is 3711.48 MXN — it has increased by 23.92% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on BMV exchange SEAGEN INC stocks are traded under the ticker SGEN.
SEAGEN INC is going to release the next earnings report on Apr 25, 2024. Keep track of upcoming events with our Earnings Calendar.
SGEN stock is 19.31% volatile and has beta coefficient of 0.03. Check out the list of the most volatile stocks — is SEAGEN INC there?
SGEN earnings for the last quarter are −19.37 MXN per share, whereas the estimation was −13.83 MXN resulting in a −40.07% surprise. The estimated earnings for the next quarter are −14.30 MXN per share. See more details about SEAGEN INC earnings.
SEAGEN INC revenue for the last quarter amounts to 10.35 B MXN despite the estimated figure of 9.60 B MXN. In the next quarter revenue is expected to reach 11.07 B MXN.
Yes, you can track SEAGEN INC financials in yearly and quarterly reports right on TradingView.
SGEN net income for the last quarter is −3.76 B MXN, while the quarter before that showed −3.63 B MXN of net income which accounts for −3.74% change. Track more SEAGEN INC financial stats to get the full picture.
No, SGEN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, SGEN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SEAGEN INC stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 24, 2024, the company has 3.26 K employees. See our rating of the largest employees — is SEAGEN INC on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SEAGEN INC technincal analysis shows the strong buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SEAGEN INC stock shows the strong buy signal. See more of SEAGEN INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SEAGEN INC EBITDA is −12.26 B MXN, and current EBITDA margin is −27.05%. See more stats in SEAGEN INC financial statements.